Britain’s health officials approve Wegovy in pill form for use, according to reporting that follows a prior announcement. The tablet version is intended as an alternative to the current once-weekly Wegovy injection. The sources describe the “Wegovy Pill” as a newly authorized option for weight loss treatment and note that it is expected to be cheaper than the injectable form. The articles reference that the update builds on earlier reporting that the pill would receive approval, stating it has now been “greenlit.” Beyond the approval and the anticipated cost difference, the available excerpts do not provide details such as the specific prescribing criteria, eligibility requirements, pricing figures, or expected availability timeline. The information presented is limited to the authorization and the claim that the pill format will reduce costs relative to injections. Additional specifics from the approving authorities are not included in the provided text.